TY - JOUR
T1 - Mutant huntingtin interacts with β-tubulin and disrupts vesicular transport and insulin secretion
AU - Smith, Ruben
AU - Bacos, Karl
AU - Fedele, Valentina
AU - Soulet, Denis
AU - Walz, Helena A.
AU - Obermüller, Stefanie
AU - Lindqvist, Anders
AU - Björkqvist, Maria
AU - Klein, Pontus
AU - Önnerfjord, Patrik
AU - Brundin, Patrik
AU - Mulder, Hindrik
AU - Li, Jia Yi
PY - 2009
Y1 - 2009
N2 - Huntington's disease is a severe progressive neurodegenerative disorder caused by a CAG expansion in the IT15 gene, which encodes huntingtin. The disease primarily affects the neostriatum and cerebral cortex and also associates with increased incidence of diabetes. Here, we show that mutant huntingtin disrupts intracellular transport and insulin secretion by direct interference with microtubular β-tubulin. We demonstrate that mutant huntingtin impairs glucose-stimulated insulin secretion in insulin-producing β-cells, without altering stored levels of insulin. Using VSVG-YFP, we show that mutant huntingtin retards post-Golgi transport. Moreover, we demonstrate that the speed of insulin vesicle trafficking is reduced. Using immunoprecipitation of mutant and wild-type huntingtin in combination with mass spectrometry, we reveal an enhanced and aberrant interaction between mutant huntingtin and β-tubulin, implying the underlying mechanism of impaired intracellular transport. Thus, our findings have revealed a novel pathogenetic process by which mutant huntingtin may disrupt hormone exocytosis from β-cells and possibly impair vesicular transport in any cell that expresses the pathogenic protein.
AB - Huntington's disease is a severe progressive neurodegenerative disorder caused by a CAG expansion in the IT15 gene, which encodes huntingtin. The disease primarily affects the neostriatum and cerebral cortex and also associates with increased incidence of diabetes. Here, we show that mutant huntingtin disrupts intracellular transport and insulin secretion by direct interference with microtubular β-tubulin. We demonstrate that mutant huntingtin impairs glucose-stimulated insulin secretion in insulin-producing β-cells, without altering stored levels of insulin. Using VSVG-YFP, we show that mutant huntingtin retards post-Golgi transport. Moreover, we demonstrate that the speed of insulin vesicle trafficking is reduced. Using immunoprecipitation of mutant and wild-type huntingtin in combination with mass spectrometry, we reveal an enhanced and aberrant interaction between mutant huntingtin and β-tubulin, implying the underlying mechanism of impaired intracellular transport. Thus, our findings have revealed a novel pathogenetic process by which mutant huntingtin may disrupt hormone exocytosis from β-cells and possibly impair vesicular transport in any cell that expresses the pathogenic protein.
UR - http://www.scopus.com/inward/record.url?scp=70349569018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349569018&partnerID=8YFLogxK
U2 - 10.1093/hmg/ddp336
DO - 10.1093/hmg/ddp336
M3 - Article
C2 - 19628478
AN - SCOPUS:70349569018
SN - 0964-6906
VL - 18
SP - 3942
EP - 3954
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 20
ER -